Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'btk inhibitor 1'

Search results for: 'btk inhibitor 1'

Items 1-10 of 43

Page
per page
  1. PF-543
    A3717 PF-543
     1 Citation
    Target: Sphingosine kinases (SphKs)
    Summary: SphK1 inhibitor,cell-permeate,potent and selective
      ≥23.3 mg/mL
  2. 1-Oleoyl lysophosphatidic acid sodium salt
    B7515 1-Oleoyl lysophosphatidic acid sodium salt
    Target: LPA Receptors
    Summary: Activates LPA receptor
      methanol
  3. SCH 527123
    A3802 SCH 527123
     5 Citation
    Target: CXCR
    Summary: CXCR1 and CXCR2 receptors antagonist
  4. SKI II
    B2226 SKI II
    Target: Sphingosine kinases (SphKs)
    Summary: Sphingosine kinase(SK) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.15 mg/mL
  5. Pentostatin
    A3708 Pentostatin
     1 Citation
    Target: Adenosine Deaminases
    Summary: Irreversible adenosine deaminase inhibitor
      ≥26.8 mg/mL
  6. Rimonabant
    B1429 Rimonabant
     3 Citation
    Target: CB1 Receptors|CB2 Receptors
    Summary: CB1 receptor antagonist
      ≥23.19 mg/mL
  7. Olanzapine
    B2240 Olanzapine
    Target: 5-HT2 Receptors|D2 Receptors
    Summary: Antagonist of 5-HT2A and dopamine D2 receptors
      insoluble in H2O; ≥15.6 mg/mL
  8. Tizanidine HCl
    B1368 Tizanidine HCl
    Summary: α2-adrenergic receptor agonist
      ≥14.51 mg/mL
  9. Naratriptan
    B2251 Naratriptan
    Target: 5-HT1 Receptor
    Summary: selective 5-HT1 receptor subtype agonist
      insoluble in H2O; ≥61.1 mg/mL
  10. DOI hydrochloride
    B5321 DOI hydrochloride
    Target: 5-HT2 Receptors
    Summary: A brain-permeable 5-HT2A/5-HT2C receptor agonist
      Soluble in H2O

Items 1-10 of 43

Page
per page
Shop By
Now Shopping by
  1. Category GPCR/G protein Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. 5-HT Receptor 11item
  2. Adenosine Receptor 2item
  3. Adenosine Kinase 2item
  4. Adrenergic Receptor 3item
  5. Angiotensin Receptor 6item
  6. Cannabinoid Receptor 2item
  7. CCR2 1 item
  8. CXCR 4item
  9. ETB Receptors 1 item
  10. Free Fatty Acid Receptors 1 item
  11. Glucagon Receptor 3item
  12. Leukotriene Receptor 1 item
  13. LPA Receptor 3item
  14. S1P receptor 2item
  15. Ras 1 item
Specificity
  1. Selective 33item
Reversibility
  1. Reversible 1 item
  2. Irreversible 1 item
Target
  1. Adenosine A2A Receptors 1 item
  2. CXCR 4item
  3. Voltage-gated Potassium (KV) Channels 1 item
  4. LPA Receptors 3item
  5. Glucagon-like peptide 1 (GLP-1) receptors 2item
  6. Trk Receptors 1 item
  7. CCR 1 item
  8. Angiotensin AT2 Receptors 1 item
  9. Adenosine Kinases 2item
  10. 5-HT2 Receptors 5item
  11. Insulin and Insulin-like Receptors 1 item
  12. CB1 Receptors 2item
  13. Sphingosine kinases (SphKs) 2item
  14. D2 Receptors 2item
  15. 5-HT1 Receptors 1 item
  16. 5-HT7 Receptors 1 item
  17. Serotonin reuptake 1 item
  18. Angiotensin-Converting Enzymes (ACEs) 1 item
  19. Free Fatty Acid Receptors 1 item
  20. Leukotriene and Related Receptors 1 item
  21. Norepinephrine transporter 1 item
  22. 5-HT Transporters 2item
  23. CB2 Receptors 1 item
  24. Norepinephrine transporters 1 item
  25. Angiotensin AT1 Receptors 3item
  26. Na /Ca2 Exchangers (NCXs) 1 item
  27. Glucagon Receptors 1 item
  28. ETA Receptors 1 item
  29. ETB Receptors 1 item
  30. 5-HT1 Receptor 1 item
  31. neprilysin 1 item
  32. 5-HT4 Receptor 1 item
  33. Adenosine Deaminases 1 item
  34. Serotonin (5-HT) reuptake 1 item
Related Disease
  1. Acute Kidney Injury 1 item
  2. Bladder Diseases 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 2item
  5. Cancer 11item
  6. Colorectal Cancer 3item
  7. Depression 1 item
  8. Glioblastoma 1 item
  9. Heart Failure 1 item
  10. HIV Infections 1 item
  11. Inflammatory Diseases 3item
  12. Kidney Injury Studies 1 item
  13. Leukemia 1 item
  14. Lymphoma 1 item
  15. Melanoma 1 item
  16. Schizophrenia 3item
  17. Squamous Cell Carcinoma 1 item
  18. Type 2 Diabetes 6item